The deal provides access to a lucrative respiratory drug market as the company seeks to rebuild its pipeline.
This speculative drug stock is targeting the growing global problem of hospital-based infections.
The stock has had a great run, meeting aggressive targets.
These defensive plays yield up to 8%. And best of all, it's not too late to buy.
Some major branded drugs will lose patent protection, and market share along with it, this year.
The pharmaceutical company's new CEO formerly worked for the Canadian company, long a rumored suitor.
The biotech was rumored to be a takeover target but aims to be a buyer instead.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Ukraine crisis festers and other fresh concerns boil to the surface, knocking down markets and giving volatility some life.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
A new survey by MoneyRates.com gives a glimpse into what a little financial education can do.
Six weeks later, most Americans have forgotten about the 2014 tax season -- except those who didn't file by the April 15 deadline.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'